Articles

T1D Exchange Clinic Registry Data Part of Many Studies Presented At ADA 79th Scientific Sessions

On the same month of the biggest conference of the year, T1D Exchange announces the launch of a new T1D Exchange Registry.

A Lifetime with Type 1 Diabetes, a Career of Service to the Type 1 Diabetes Community

A profile of Charlie Iacono, managing director of commercial partnerships and advancement for T1D Exchange.

T1D Exchange and DreaMed Diabetes Formalize Partnership to Optimize Insulin Treatment Plans in Clinics

Type 1 diabetes decision support technology analyzes patient data from variety of devices to determine insulin delivery recommendations for maintaining balanced glucose levels.

T1D Exchange Names Glooko as Data Management Partner in Quality Improvement Collaborative

The partnership promises secure integration of diabetes device data in an extensive type 1 diabetes data platform to drive more accurate decisions in treatment and care.

Meet the Registry Team

Meet the Registry

Get to know the team behind the T1D Exchange Registry

 “He didn’t need to die, this Alec Smith.”

In defense of her decision to vote down a bill to provide emergency insulin, Minnesota state senator Karin Housley appears to suggest that a Minnesotan with type 1 diabetes didn’t need to ration insulin before he died in 2017.

Patch CGM Approved for Use in Europe

Patch CGM Approved for Use in Europe

Nemaura plans to initially market the SugarBEAT patch CGM, which has predictive glucose alarms, to people with type 2 diabetes.

This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their type 1 diabetes in order to help researchers develop more targeted and effective approaches to treating and living with the disease.

Eylea Injection for Diabetic Retinopathy Receives FDA Approval

The new treatment received approval after positive results were released earlier this year from the PANORAMA trial.

Insulin Affordability Advocates Decry Demise of Minnesota Emergency Insulin Access Bill

The bill, which initially was passed by both chambers of the state legislature, ultimately failed to pass in the state senate during a closed-door session.